For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a ...

Multiple sclerosis, a complex neurological condition affecting nearly 3 million people worldwide, has long been characterized by its elusiveness. Even as medical imaging technology has advanced ...

Women with relapsing-remitting multiple sclerosis (MS), particularly after menopause, experienced a higher risk of relapse-independent worsening, whereas men showed a greater worsening of disability ...

Researchers have identified biomarkers that can predict disease progression in multiple sclerosis, which could lead to the development of more personalized treatment strategies. Multiple sclerosis (MS ...

Increases in sGFAP during BCDT are linked to disability progression in MS, independent of relapse activity. sGFAP is a stronger predictor of disease progression than sNfL, reflecting different ...

NEW ORLEANS — The degree of meningeal inflammation and cortical pathology might prove useful for stratifying patients with early progressive multiple sclerosis (MS), new research suggests. The ...

Signs of multiple sclerosis may surface years before diagnosis, as patients use healthcare more often for early symptoms.

A fascinating breakthrough in multiple sclerosis research reveals that the microscopic organisms living in our digestive systems might hold crucial clues about the disease’s development and severity.

A recent study revealed a new approach to monitoring the progression of multiple sclerosis (MS) using everyday wearable technology. The study, conducted by researchers from ETH Zurich, University ...